{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T17:06:53Z","timestamp":1695575213886},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"crossref","award":["Z2007C16"],"award-info":[{"award-number":["Z2007C16"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.intimp.2011.03.022","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T23:51:08Z","timestamp":1303170668000},"page":"1211-1219","source":"Crossref","is-referenced-by-count":3,"title":["Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children"],"prefix":"10.1016","volume":"11","author":[{"given":"Ling-zhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9617","key":"10.1016\/j.intimp.2011.03.022_bb0005","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2011.03.022_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.60.041807.132435","article-title":"Evolving treatment of advanced colon cancer","volume":"60","author":"Segal","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.intimp.2011.03.022_bb0015","first-page":"1284","article-title":"Novel agents in the management of lung cancer","volume":"10","author":"Kennedy","year":"2010","journal-title":"Curr Med Chem Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00277-003-0752-8","article-title":"Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects","volume":"83","author":"Gokbuget","year":"2004","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.intimp.2011.03.022_bb0025","first-page":"388","article-title":"New combination therapies in hematological malignancies","volume":"27","author":"Takeshita","year":"2000","journal-title":"Gan To Kagaku Ryoho"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0030","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/07357900902897557","article-title":"CD10 and CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome","volume":"26","author":"Dakka","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.intimp.2011.03.022_bb0035","first-page":"111","article-title":"Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia","volume":"20","author":"Sidhom","year":"2008","journal-title":"J Egypt Natl Canc Inst"},{"key":"10.1016\/j.intimp.2011.03.022_bb0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1053\/j.gastro.2010.05.084","article-title":"CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer","volume":"139","author":"Ikenaga","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2011.03.022_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cyto.b.20071","article-title":"Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group","volume":"68","author":"Borowitz","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"issue":"11","key":"10.1016\/j.intimp.2011.03.022_bb0050","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/sj.bjc.6600329","article-title":"CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL","volume":"86","author":"Cutrona","year":"2002","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2011.03.022_bb0055","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.intimp.2011.03.022_bb0060","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1349-7006.2010.01583.x","article-title":"Adjuvant engineering for cancer immunotherapy: development of a synthetic TLR2 ligand with increased cell adhesion","volume":"101","author":"Akazawa","year":"2010","journal-title":"Cancer Sci"},{"issue":"10","key":"10.1016\/j.intimp.2011.03.022_bb0065","doi-asserted-by":"crossref","first-page":"e13571","DOI":"10.1371\/journal.pone.0013571","article-title":"Bacillus Calmette Guerin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model","volume":"5","author":"Lodillinsky","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2011.03.022_bb0070","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.intimp.2010.07.012","article-title":"Induction of dendritic cell maturation by beta-glucan isolated from Sparassis crispa","volume":"10","author":"Kim","year":"2010","journal-title":"Int Immunopharmacol"},{"issue":"11\u201312","key":"10.1016\/j.intimp.2011.03.022_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2298\/MPNS0912592K","article-title":"Disseminated BCG infection in patients with urinary bladder carcinoma","volume":"62","author":"Korac","year":"2009","journal-title":"Med Pregl"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/09273948.2010.486099","article-title":"Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma","volume":"18","author":"Uppal","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.intimp.2011.03.022_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0162-3109(00)00195-8","article-title":"Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells","volume":"48","author":"Heinzelmann","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.intimp.2011.03.022_bb0090","first-page":"50","article-title":"Effect of synthetic muramyl dipeptide derivatives on staphylococcal infection in mice","volume":"3","author":"Grabchenko","year":"2001","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"issue":"10","key":"10.1016\/j.intimp.2011.03.022_bb0095","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.intimp.2006.05.004","article-title":"Immunomodulatory properties of new conjugates of muramyl dipeptide and nor-muramyl dipeptide with retro-tuftsin (Arg-Pro-Lys-Thr-OMe)","volume":"6","author":"Wardowska","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.intimp.2011.03.022_bb0100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.vaccine.2006.09.070","article-title":"Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs","volume":"25","author":"Martino","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.intimp.2011.03.022_bb0105","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.emboj.7600175","article-title":"Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition","volume":"23","author":"Tanabe","year":"2004","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0110","first-page":"963","article-title":"Effect of muramyl dipeptide on proliferation of dendritic cells derived from children acute leukemia bone marrow in vitro","volume":"18","author":"Li","year":"2010","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.intimp.2011.03.022_bb0115","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1074\/jbc.C200673200","article-title":"Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease","volume":"278","author":"Inohara","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0120","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1189\/jlb.0805484","article-title":"Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation","volume":"79","author":"Kramer","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.intimp.2011.03.022_bb0125","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/bc9004975","article-title":"Characterization and cancer cell specific binding properties of anti-EGFR antibody conjugated quantum dots","volume":"21","author":"Lee","year":"2010","journal-title":"Bioconjug Chem"},{"issue":"7","key":"10.1016\/j.intimp.2011.03.022_bb0130","first-page":"704","article-title":"Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody","volume":"42","author":"Feng","year":"2007","journal-title":"Yao Xue Xue Bao"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/CJI.0b013e31819e1773","article-title":"Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma","volume":"32","author":"Han","year":"2009","journal-title":"J Immunother"},{"issue":"9","key":"10.1016\/j.intimp.2011.03.022_bb0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.lfs.2005.05.106","article-title":"LPS-induced ROS generation and changes in glutathione level and their relation to the maturation of human monocyte-derived dendritic cells","volume":"78","author":"Yamada","year":"2006","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0145","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","article-title":"Designing vaccines based on biology of human dendritic cell subsets","volume":"33","author":"Palucka","year":"2010","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2011.03.022_bb0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2006.10.005","article-title":"Targeting dendritic cells with biomaterials: developing the next generation of vaccines","volume":"27","author":"Reddy","year":"2006","journal-title":"Trends Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2011.03.022_bb0160","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.intimp.2011.03.022_bb0165","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL-10-treated dendritic cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2011.03.022_bb0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3171\/jns.2005.103.1.0156","article-title":"Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines","volume":"103","author":"Kjaergaard","year":"2005","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.intimp.2011.03.022_bb0175","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00002371-200411000-00005","article-title":"Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12","volume":"27","author":"Kikuchi","year":"2004","journal-title":"J Immunother"},{"issue":"4","key":"10.1016\/j.intimp.2011.03.022_bb0180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/IGC.0b013e3181a44bc8","article-title":"Chemically modified heparin inhibits in vitro L-selectin-mediated human ovarian carcinoma cell adhesion","volume":"19","author":"Chen","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.intimp.2011.03.022_bb0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2172-11-6","article-title":"Antibody isotype analysis of malaria-nematode co-infection: problems and solutions associated with cross-reactivity","volume":"11","author":"Fairlie-Clarke","year":"2010","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2011.03.022_bb0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpba.2010.01.039","article-title":"Tracking of antibody reduction fragments by capillary gel electrophoresis during the coupling to microparticles surface","volume":"53","author":"Cherkaoui","year":"2010","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"10.1016\/j.intimp.2011.03.022_bb0195","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1535-7163.MCT-06-0026","article-title":"Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin\/p97","volume":"5","author":"Smith","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"10.1016\/j.intimp.2011.03.022_bb0200","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1158\/1078-0432.CCR-05-0204","article-title":"Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys","volume":"11","author":"Sapra","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.intimp.2011.03.022_bb0205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3121\/cmr.3.3.166","article-title":"Immunoregulation of dendritic cells","volume":"3","author":"Wallet","year":"2005","journal-title":"Clin Med Res"},{"issue":"11","key":"10.1016\/j.intimp.2011.03.022_bb0210","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2174\/1381612013397627","article-title":"Role of dendritic cell-derived cytokines in immune regulation","volume":"7","author":"Wan","year":"2001","journal-title":"Curr Pharm Des"},{"issue":"3\u20134","key":"10.1016\/j.intimp.2011.03.022_bb0215","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.vetimm.2007.05.010","article-title":"Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation","volume":"118","author":"Wang","year":"2007","journal-title":"Vet Immunol Immunopathol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576911001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576911001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T10:53:34Z","timestamp":1686048814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576911001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1567576911001615"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2011.03.022","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}